Fundraising Fox

Pleopharma

Phoenixville, US · Founded 2020 · Delaware corporation · 12 employees on LinkedIn

PleoPharma is a pharmaceutical company developing a treatment aimed at an unmet medical condition. It works with industry partners, healthcare providers, researchers, and investors.

BiotechHealthtech

Founders & leadership

JC
Jay ConstantineExecutive
TF
Thomas F PocheExecutive
DA
Daniel Alan CartwrightExecutive
GC
Ginger ConstantineExecutive
PB
Paul BisaroNamed on SEC filing
TT
Tommy ThompsonNamed on SEC filing
KM
Kyle MowitzNamed on SEC filing
KT
Kyle TomlinNamed on SEC filing
PT
Poche ThomasNamed on SEC filing
DC
Daniel CartwrightNamed on SEC filing
MT
McInerney TimothyNamed on SEC filing

Board

SH
Sarah HassanBoard director

Reported raises · per SEC filings

Form D private placements

$22.9M disclosed across 4 rounds · 2020–2026

▶$5.5MraisedAug 2026 · 11 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Ginger ConstantineExecutive Officer, Director
  • Jay ConstantineExecutive Officer, Director
  • Robert FinizioExecutive Officer, Director
  • Paul BisaroDirector
  • Tommy ThompsonDirector
  • Sarah HassanDirector
  • Brij SharmaDirector
  • Kyle MowitzDirector
  • Kyle TomlinDirector
  • Poche ThomasExecutive Officer
  • Daniel CartwrightExecutive Officer
  • McInerney TimothyDirector
Offering amount
$15M
Amount sold
$5.5M
Minimum investment
$50K
Sales commissions
$50K
Placement agents
Supervision Partners LLC
First sale
Jul 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.2MraisedAug 2025 · 9 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Jay ConstantineExecutive Officer, Director
  • Thomas F PocheExecutive Officer
  • Daniel Alan CartwrightExecutive Officer
  • Sarah HassanDirector
  • Timothy McInerneyDirector
  • Bisaro PaulDirector
  • Robert FinizioDirector
  • Thompson TommyDirector
  • Ginger ConstantineExecutive Officer, Director
  • Brij SharmaDirector
Offering amount
$36.2M
Amount sold
$6.2M
Minimum investment
$50K
Sales commissions
$268K
Placement agents
Castle Hill Capital Partners, Inc, Supervision Partners LLC
First sale
Jun 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$11.1MraisedMay 2022 · 47 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • JAY CONSTANTINEDirector
  • ROBERT FINIZIODirector
  • GINGER CONSTANTINEExecutive Officer, Director
  • THOMAS POCHEExecutive Officer
  • PAUL BISARODirector
  • DANIEL CARTWRITGHTExecutive Officer
Offering amount
$16.1M
Amount sold
$11.1M
Sales commissions
$131.1K
Placement agents
CASTLE HILL CAPITAL PARTNERS, INC.
First sale
May 2022
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$130KraisedFeb 2020 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jay ConstantineDirector, Promoter
  • Robert FinizioDirector, Promoter
  • Ginger ConstantineExecutive Officer, Director, Promoter
Amount sold
$130K
Minimum investment
$1K
First sale
Jan 2020
Incorporated
Limited Liability Company, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap
Pharm Int15 shared keywordsPii is a contract development and manufacturing organization (CDMO) that provides custom drug product manufacturing services, including aseptic injectables, oral dosage forms, and lyophilization. The company serves pharmaceutical companies developing and commercializing drug products across clinical and commercial phases.
Bionpharma14 shared keywords

Companies competing with Pleopharma for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Pleopharma do?
PleoPharma is a pharmaceutical company developing a treatment aimed at an unmet medical condition. It works with industry partners, healthcare providers, researchers, and investors.
How much funding has Pleopharma raised?
Pleopharma has disclosed $22.9M raised across 4 rounds.
Where is Pleopharma headquartered?
Pleopharma is headquartered in Phoenixville, US.